Open Access
Open access
Molecular Therapy - Nucleic Acids, volume 26, pages 1159-1172

11C-radiolabeled aptamer for imaging of tumors and metastases using positron emission tomography- computed tomography

Shchugoreva Irina A. 2
Zamay Galina S
Kolovskaya Olga S
Zabluda Vladimir N 3
Veprintsev Dmitry V
Sil’nikov Vladimir N
Shepelevich Nikolay 1
Zamay Tatiana N.
Zamay Sergey S
Belugin Kirill V
Chanchikova Natalia G
Badmaev Oleg N 1
Khorzhevskii Vladimir A
Gappoev Stanislav V
Karlova Elena A 1
Saveleva Anastasia S 1
Volzhentsev Alexander A 1
Blagodatova Anna N 5
Smolyarova Tatyana E 2
Kolovskaya Olga S. 5
Belugin Kirill 1
Chanchikova Natalia 1
Zamay Galina S. 5
Khorzhevskii Vladimir A 5
Gappoev Stanislav V 5
Veprintsev Dmitry B. 2
Zamay Sergey S. 2
SILNIKOV VLADIMIR 6
Publication typeJournal Article
Publication date2021-12-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor8.8
ISSN21622531
Drug Discovery
Molecular Medicine
Abstract
Identification of primary tumors and metastasis sites is an essential step in cancer diagnostics and the following treatment. Positron emission tomography-computed tomography (PET/CT) is one of the most reliable methods for scanning the whole organism for malignancies. In this work, we synthesized an 11C-labeled oligonucleotide primer and hybridized it to an anti-cancer DNA aptamer. The 11C-aptamer was applied for in vivo imaging of Ehrlich ascites carcinoma and its metastases in mice using PET/CT. The imaging experiments with the 11C-aptamer determined very small primary and secondary tumors of 3 mm2 and less. We also compared 11C imaging with the standard radiotracer, 2-deoxy-2-[fluorine-18]fluoro-D-glucose (18F-FDG), and found better selectivity of the 11C-aptamer to metastatic lesions in the metabolically active organs than 18F-FDG. 11C radionuclide with an ultra-short (20.38 min) half-life is considered safest for PET/CT imaging and does not cause false-positive results in heart imaging. Its combination with aptamers gives us high-specificity and high-contrast imaging of cancer cells and can be applied for PET/CT-guided drug delivery in cancer therapies.

Citations by journals

1
Journal of Chemical Physics
Journal of Chemical Physics, 1, 10%
Journal of Chemical Physics
1 publication, 10%
Journal Physics D: Applied Physics
Journal Physics D: Applied Physics, 1, 10%
Journal Physics D: Applied Physics
1 publication, 10%
Cancer Biotherapy and Radiopharmaceuticals
Cancer Biotherapy and Radiopharmaceuticals, 1, 10%
Cancer Biotherapy and Radiopharmaceuticals
1 publication, 10%
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids, 1, 10%
Molecular Therapy - Nucleic Acids
1 publication, 10%
Methods in Enzymology
Methods in Enzymology, 1, 10%
Methods in Enzymology
1 publication, 10%
PLoS ONE
PLoS ONE, 1, 10%
PLoS ONE
1 publication, 10%
Chemical Science
Chemical Science, 1, 10%
Chemical Science
1 publication, 10%
Biomedical Materials (Bristol)
Biomedical Materials (Bristol), 1, 10%
Biomedical Materials (Bristol)
1 publication, 10%
Russian Journal of Oncology
Russian Journal of Oncology, 1, 10%
Russian Journal of Oncology
1 publication, 10%
EJNMMI Research
EJNMMI Research, 1, 10%
EJNMMI Research
1 publication, 10%
1

Citations by publishers

1
2
IOP Publishing
IOP Publishing, 2, 20%
IOP Publishing
2 publications, 20%
Elsevier
Elsevier, 2, 20%
Elsevier
2 publications, 20%
American Institute of Physics (AIP)
American Institute of Physics (AIP), 1, 10%
American Institute of Physics (AIP)
1 publication, 10%
Mary Ann Liebert
Mary Ann Liebert, 1, 10%
Mary Ann Liebert
1 publication, 10%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 1, 10%
Public Library of Science (PLoS)
1 publication, 10%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 10%
Royal Society of Chemistry (RSC)
1 publication, 10%
Eco-Vector LLC
Eco-Vector LLC, 1, 10%
Eco-Vector LLC
1 publication, 10%
Springer Nature
Springer Nature, 1, 10%
Springer Nature
1 publication, 10%
1
2
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Ozerskaya A. V. et al. 11C-radiolabeled aptamer for imaging of tumors and metastases using positron emission tomography- computed tomography // Molecular Therapy - Nucleic Acids. 2021. Vol. 26. pp. 1159-1172.
GOST all authors (up to 50) Copy
Zamay T. N., Kichkailo A. S., Berezovski M. V., Sil’nikov V. N., Zamay S. S., Tomilin F. N., Smolyarova T. E., Veprintsev D. V., Lukyanenko K. A., Blagodatova A. N., Volzhentsev A. A., Saveleva A. S., Karlova E. A., Shepelevich N., Ozerskaya A. V., Kolovskaya O. S., Tokarev N. A., Belugin K. V., Chanchikova N. G., Badmaev O. N., Shchugoreva I. A., Moryachkov R. V., Zabluda V. N., Khorzhevskii V. A., Gappoev S. V., Zamay G. S., Zamay T. N., Kolovskaya O. S., Belugin K., Chanchikova N., Zamay G. S., Khorzhevskii V. A., Gappoev S. V., Veprintsev D. B., Zamay S. S., SILNIKOV V., Kichkailo A. S. 11C-radiolabeled aptamer for imaging of tumors and metastases using positron emission tomography- computed tomography // Molecular Therapy - Nucleic Acids. 2021. Vol. 26. pp. 1159-1172.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.omtn.2021.10.020
UR - https://doi.org/10.1016%2Fj.omtn.2021.10.020
TI - 11C-radiolabeled aptamer for imaging of tumors and metastases using positron emission tomography- computed tomography
T2 - Molecular Therapy - Nucleic Acids
AU - Ozerskaya, Anastasia V
AU - Zamay, Tatiana N.
AU - Kolovskaya, Olga S
AU - Tokarev, Nikolay A
AU - Belugin, Kirill V
AU - Chanchikova, Natalia G
AU - Badmaev, Oleg N
AU - Zamay, Galina S
AU - Shchugoreva, Irina A.
AU - Moryachkov, R V
AU - Zabluda, Vladimir N
AU - Khorzhevskii, Vladimir A
AU - Shepelevich, Nikolay
AU - Gappoev, Stanislav V
AU - Karlova, Elena A
AU - Saveleva, Anastasia S
AU - Volzhentsev, Alexander A
AU - Blagodatova, Anna N
AU - Lukyanenko, Kirill A.
AU - Veprintsev, Dmitry V
AU - Smolyarova, Tatyana E
AU - Tomilin, Felix N.
AU - Zamay, Sergey S
AU - Sil’nikov, Vladimir N
AU - Berezovski, Maxim V.
AU - Kichkailo, Anna S.
AU - Zamay, Tatiana N.
AU - Kolovskaya, Olga S.
AU - Belugin, Kirill
AU - Chanchikova, Natalia
AU - Zamay, Galina S.
AU - Khorzhevskii, Vladimir A
AU - Gappoev, Stanislav V
AU - Veprintsev, Dmitry B.
AU - Zamay, Sergey S.
AU - SILNIKOV, VLADIMIR
AU - Kichkailo, Anna S
PY - 2021
DA - 2021/12/01 00:00:00
PB - Elsevier
SP - 1159-1172
VL - 26
PMID - 34853715
SN - 2162-2531
ER -
BibTex
Cite this
BibTex Copy
@article{2021_Ozerskaya,
author = {Anastasia V Ozerskaya and Tatiana N. Zamay and Olga S Kolovskaya and Nikolay A Tokarev and Kirill V Belugin and Natalia G Chanchikova and Oleg N Badmaev and Galina S Zamay and Irina A. Shchugoreva and R V Moryachkov and Vladimir N Zabluda and Vladimir A Khorzhevskii and Nikolay Shepelevich and Stanislav V Gappoev and Elena A Karlova and Anastasia S Saveleva and Alexander A Volzhentsev and Anna N Blagodatova and Kirill A. Lukyanenko and Dmitry V Veprintsev and Tatyana E Smolyarova and Felix N. Tomilin and Sergey S Zamay and Vladimir N Sil’nikov and Maxim V. Berezovski and Anna S. Kichkailo and Tatiana N. Zamay and Olga S. Kolovskaya and Kirill Belugin and Natalia Chanchikova and Galina S. Zamay and Vladimir A Khorzhevskii and Stanislav V Gappoev and Dmitry B. Veprintsev and Sergey S. Zamay and VLADIMIR SILNIKOV and Anna S Kichkailo},
title = {11C-radiolabeled aptamer for imaging of tumors and metastases using positron emission tomography- computed tomography},
journal = {Molecular Therapy - Nucleic Acids},
year = {2021},
volume = {26},
publisher = {Elsevier},
month = {dec},
url = {https://doi.org/10.1016%2Fj.omtn.2021.10.020},
pages = {1159--1172},
doi = {10.1016/j.omtn.2021.10.020}
}
Found error?